Regeneron and Sanofi announced Kevzara (sarilumab) phase 3 US trial in COVID-19 patients did not meet endpoints
On Jul. 2, 2020, Regeneron and Sanofi announced that the U.S. Phase 3 trial of Kevzara (sarilumab) 400…
Ceres’ published data demonstrated a rapid and versatile method for improving detection of SARS-CoV-2
On Jul. 2, 2020, Ceres Nanosciences and its collaborators at George Mason University announced they had have developed…
Intravacc in-licensed CimCure’s iBoost technology, expanding its vaccine platform portfolio
On Jul. 1, 2020, Intravacc announced the signing of a strategic partnership agreement with Dutch based CimCure, focusing…
Complexity of human tooth enamel revealed at atomic level in NIH-funded study
On Jul. 1, 2020, National Institutes of Health (NIH) funded scientists announced using a combination of advanced microscopy…
NIH ACTIV vaccine working group weighed role of human challenge studies for SARS-CoV-2 vaccine development
On Jul. 1, 2020, in a Perspective for the New England Journal of Medicine, members of the NIHï¾’s…
Fujifilm partnered with Dr. Reddy’s and Global Response Aid for deployment of a COVID-19 treatment drug outside of Japan
On Jul. 1, 2020, FUJIFILM announced a partnership with Dr. Reddy’s Laboratories, a global pharmaceutical company headquartered in…
MediciNova announced IND for MN-166 (ibudilast) for prevention of ARD Syndrome in patients with COVID-19
On Jul. 1, 2020, MediciNova announced that the Investigational New Drug Application (IND) for MN-166 (ibudilast) for prevention…
Merck and Ridgeback Bio announced closing of collaboration and licensing transaction
On Jul. 1, 2020, Merck and and and Ridgeback Biotherapeutics announced that the U.S. Federal Trade Commission (FTC)…
T2 Biosystems announces US launch of COVID-19 diagnostic test
On Jul. 1, 2020, T2 Biosystems announced completion of validation of its COVID-19 molecular diagnostic test, the T2SARS-CoV-2…
OPKO Health’s BioReference Laboratories reports results of COVID-19 testing for almost one quarter of a million nursing home employees
On Jul. 1, 2020, OPKO Health announced the results of COVID-19 molecular PCR and antibody tests for nursing…
Pfizer and BioNTech announced early positive data from ongoing phase 1/2 study of mRNA-based vaccine candidate against SARS-CoV-2
On Jul. 1, 2020, Pfizer and BioNTech announced preliminary data from the most advanced of four investigational vaccine…
InBios received FDA Emergency Use Authorization for second COVID-19 antibody test
On Jul. 1, 2020, InBios announced that it had received Emergency Use Authorization (EUA) from the FDA for…
UC Berkeley launched trial of saliva test for COVID-19
On Jun. 30, 2020, scientists from the Innovative Genomics Institute (IGI) at the University of California Berkeley announced…
Successful first harvest provided roadmap for scaling secure, domestic source of farm-raised salmon
On Jun. 30, 2020, AquaBounty Technologies announced it had successfully commenced the commercial-scale harvest of conventional Atlantic salmon…
Altimmune announces dosing of first patient in phase 1b clinical trial of NasoShieldï¾™ single dose intranasal anthrax vaccine candidate
On Jun. 30, 2020, Altimmune announced dosing of the first patient in the Companyï¾’s Phase 1b clinical trial…
Gilead Sciences announced Covid-19 drug Remdesivir to cost $3,120 for typical patient on private insurance
On Jun. 29, 2020, Gilead Sciences announced that the Covid-19 drug Remdesivir will cost $3,120 for typical patient…
NIH study showed genomic variation causing common autoinflammatory disease may increase resilience to bubonic plague
On Jun. 29, 2020, NIIH researchers announced they had discovered that Mediterranean populations may be more susceptible to…
U.S. Dept of Veterans Affairs launched COVID-19 screening tool
On Jun. 29, 2020, the U.S. Dept. of Veterans Affairs (VA) announced it had launched a digital COVID-19…
Oxford University dashboard highlighted potential future COVID-19 virus hotspots
On Jun. 29, 2020, the University of Oxford reported that potential COVID-19 hotspots can be identified using a…
Bharat Biotech COVID-19 vaccine – COVAXINTM received DCGI approval for phase I & II Human clinical trials
On Jun. 29, 2020, Bharat Biotech has successfully developed COVAXINï¾™, Indiaï¾’s 1stvaccine candidate for COVID-19, in collaboration with…
Association between statewide school closure and COVID-19 incidence and mortality in the US
On Jun. 29, 2020, JAMA reported that U.S. populationï¾–based time series analysis conducted between March 9, 2020, and…
MSFHR funded COVID-19 research to mitigate effects on BC’s vulnerable populations
On Jun. 29, 2020, the Michael Smith Foundation for Health Research (MSFHR) COVID-19 Research Response Fund announced funding…
Altimmune received award from US DoD to fund phase 1/2 clinical trial of T-COVIDï¾™ in outpatients with early COVID-19
On Jun. 29, 2020, Altimmune announced it was awarded $4.7 million from the U.S. Army Medical Research &…
LabCorp introduced Xcellerateï¾® COVID-19 clinical study solution
On Jun. 29, 2020, LabCorpï¾® announced that Covance, its drug development business, has deployed the Xcellerateï¾® COVID-19 solution…
Todos Medical entered into distribution partnership with Meridian Health Services network for COVID-19 testing solutions
On Jun. 29, 2020, Todos Medical announced that it had entered into a partnership with Meridian Health Services…
Luminex submitted Emergency Use Authorization request to FDA for COVID-19 antibody test
On Jun. 29, 2020, Luminex announced that the company had submitted an Emergency Use Authorization request to the…
Experts identifed steps to expand and improve antibody tests in COVID-19 response
On Jun. 26, 2020, more than 300 scientists and clinicians from the federal government, industry and academia published…
COVID-19 Therapeutics Accelerator donors launched international alliance to connect research data sources and enable collaboration
On Jun. 26, 2020, the COVID-19 Therapeutics Accelerator donors and partners announced the formation of the International COVID-19…
Vaxart signed Memorandum of Understanding with Attwill Medical Solutions Sterilflow
On Jun. 26, 2020, Vaxart announced that its oral COVID-19 vaccine had been selected to participate in a…
CIRM board approved third clinical trial for COVID-19
On Jun. 26, 2020, the California Institute for Regenerative Medicine (CIRM) awarded $750,000 to Dr. Xiaokui Zhang at…